webinar register page

Doing things differently: the UK's ambitions in the life sciences sector
The UK government is building on its established position in R&D, its response to the pandemic, and the opportunities available to the UK since leaving the EU’s regulatory orbit. It has already been exploring innovation in policy frameworks and is likely to go further, on issues such as health data, gene editing and personalised genomics, advanced manufacturing and new commercial models to accelerate access to new therapies.

Join Health Practice Lead Tom Smith, Senior Associate Giulia Corsi and GC Adviser Dr. Harpreet Sood, on a call to explore these opportunities, including:

- How the life sciences sector fits within the government’s wider post covid economic plans
- What regulatory changes could help drive innovation in the UK
- What the potential challenges and consequences are of diverging from the EU
- Which markets and assets will be particularly appealing to investors as a result

Apr 21, 2021 08:00 AM in London

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.